Regulus Reports Clinical Hold of RG-101
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/12/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Regulus Therapeutics (RGLS) PT Lowered to $9 at FBR
June 28, 2016 1:35 PM EDTFBR Capital analyst Christopher James lowered his price target on Regulus Therapeutics (NASDAQ: RGLS) to $9.00 (from $30.00) following the FDA clinical hold on RG-101 but maintained a Buy rating.
James commented, "We are lowering our price target to $9 on shares of RGLS, following Regulus' announcement yesterday that the FDA has placed its... More
Regulus Therapeutics (RGLS) PT Cut to $13.50 at Chardan Capital Following Clinical Hold
June 28, 2016 7:38 AM EDTChardan Capital Markets analyst Madhu Kumar lowered his price target on Regulus Therapeutics (NASDAQ: RGLS) 33% to $13.50 after the company announced the start of a clinical hold for RG-101 in the treatment of chronic hepatitis C virus (HCV).
Based upon the clinical hold, the firm now lowers their peak risk-adjusted RG-101 sales to $1.2 bn and NPV to $9.24... More
BMO Capital Downgrades Regulus Therapeutics (RGLS) to Market Perform
June 28, 2016 6:39 AM EDTBMO Capital downgraded Regulus Therapeutics (NASDAQ: RGLS) from Outperform to Market Perform with a price target of $4.00 (from $16.00).
Analyst Matthew Luchini commented, "We are downgrading RGLS shares to Market Perform following the announcement that FDA has placed a clinical hold on... More
Regulus Therapeutics (RGLS) Shares Plummet Upon Resumption
June 27, 2016 4:45 PM EDTRegulus Therapeutics (NASDAQ: RGLS) shares resume trading, the stock is down over 50% in after-hours trading.
... MoreRegulus Therapeutics (RGLS) to Resume Trading at 4:40 PM ET
June 27, 2016 4:19 PM EDTRegulus Therapeutics (NASDAQ: RGLS) to Resume Trading at 4:40 PM ET
... More